Tuberculosis eradication versus control
International Journal of Infectious Diseases·
- DOI
- 10.1016/j.ijid.2016.11.007
- PMID
- 27872016
- PMCID
- —
- OpenAlex
- W2555415627
- Study type
- Journal article
- Publisher
- Elsevier BV
- Article type
- journal-article
- Integrity
- current
Why this research matters now
The article highlights programmatic priorities related to tuberculosis diagnosis, treatment access, drug resistance, infection control, vaccination research, and financial support for national programs. These points provide policy and research context but do not establish effects of any intervention.
Structured evidence summary
Research question
The article discusses whether tuberculosis eradication targets are achievable and identifies challenges that must be addressed under the WHO End TB Strategy.
Study design
This is a peer-reviewed journal article presenting a discussion of tuberculosis eradication and control priorities. The supplied abstract does not describe a primary study population, data collection method, or statistical analysis.
Population and setting
The discussion concerns tuberculosis globally, including settings where treatment delays and medicine stock-outs are described. No defined participant sample or specific study site is provided.
Main findings
The article identifies improved detection and treatment of drug-susceptible and drug-resistant tuberculosis, infection control, patient-cost reduction, and stronger funding as priorities. It also reports that the multidrug-resistant tuberculosis cure rate was 50% and characterizes a vaccine becoming available by 2025 as highly improbable.
Public-health relevance
The article highlights programmatic priorities related to tuberculosis diagnosis, treatment access, drug resistance, infection control, vaccination research, and financial support for national programs. These points provide policy and research context but do not establish effects of any intervention.
Important limitations
The supplied material does not state formal article limitations or provide enough methodological detail to assess the basis of the reported estimates and projections. This summary is limited to the supplied single-article abstract and metadata; the original paper is required for decision-grade interpretation.
GIDS interpretation
The article is discoverable as global tuberculosis literature involving antimicrobial resistance, transmission dynamics, treatment, and vaccination. This classification provides topic context only and does not connect the article to a current surveillance signal or confirm surveillance data.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 10 auditable classifier relationships to diseases, places, topics, and study design.